CMBA
CELG

C.M. Bidwell & Associates’s Celgene Corp CELG Stock Holding History

C.M. Bidwell & Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,535
Closed -$370K – 468
2017
Q3 		$370K Sell
2,535
-35,225
-93% -$4.8M 0.57% 62
2017
Q2 		$4.9M Buy
37,760
+25
+0.1% +$3.06K 1.05% 30
2017
Q1 		$4.7M Sell
37,735
-15
-0% -$1.79K 1.06% 28
2016
Q4 		$4.37M Buy
37,750
+1,730
+5% +$193K 1.03% 27
2016
Q3 		$3.77M Buy
+36,020
New +$3.9M 0.9% 54

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

C.M. Bidwell & Associates's CELG Position: Q4 2017 in Review

C.M. Bidwell & Associates sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 2,535 shares — an estimated $370K sold.

C.M. Bidwell & Associates first reported a position in CELG in Q3 2016 and held it in 5 quarters. The position peaked at $4.9M in Q2 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • C.M. Bidwell & Associates reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 2,535 Celgene Corp shares in Q4 2017, an estimated $370K.
  • C.M. Bidwell & Associates first reported a position in Celgene Corp in Q3 2016 and held it in 5 quarters.
  • C.M. Bidwell & Associates's Celgene Corp position peaked at $4.9M in Q2 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on C.M. Bidwell & Associates's 13F filing for Q4 2017, filed 2 Feb 2018.